Impact of “hybrid therapy” on long-term rhythm control and arrhythmia related hospitalizations in patients with drug-refractory persistent and permanent atrial fibrillation

Article
First Online:
Received:
Accepted:

Abstract

Background

Recently, a “hybrid therapy” strategy has been used for successful rhythm control in persistent and permanent atrial fibrillation (AF) patients. The impact of this strategy on arrhythmia recurrences and subsequent AF related hospitalizations are unknown.

Materials and Methods

Forty-seven patients (66 ± 10 years) with symptomatic persistent (N = 26) or permanent (N = 21) AF underwent “hybrid therapy” and were followed for 24 ± 15 months. All patients underwent linear right atrial ablation and implantation of pacemaker or atrioventricular defibrillator (AVICD) capable of continuous right atrial pacing with previously ineffective antiarrhythmic drug therapy for AF prevention. Device data-logs were used to monitor AF recurrences.

Results

Freedom from permanent AF was 97, 90, and 83% at 6 months, 2 and 3 years, respectively. Sixteen patients (34%) had no recurrent AF after “hybrid therapy.” Thirty-one patients (66%) had a total of 55 AF recurrences (mean 1.8 per patient). There was a significant reduction in the mean AF related hospitalizations (from 3.5 ± 2.8 to 0.57 ± 1.1 per patient), cardioversion hospitalizations (from 3.5 ± 2.2 to 0.38 ± 0.5 per patient) and DC cardioversions (from 3.1 ± 3.9 to 0.7 ± 0.5 per patient) after hybrid therapy compared to event rates before therapy (p < 0.05 for all).

Conclusions

Rhythm control improves significantly with hybrid therapy in patients with persistent and permanent AF refractory to drugs and cardioversion therapy. This improvement is associated with a significant reduction in AF related hospitalizations and need for cardioversion therapy.

Keywords

Atrial fibrillation Antiarrhythmic therapy Cardiac pacing Atrial defibrillators Hybrid therapy Economics Cardioversion Catheter ablation 

Abbreviations

AF

Atrial Fibrillation

AVICD

Atrioventricular Impantable Cardioverter-Defibrillator (also referred to as DDED ICD)

This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Filipecki, A., Saksena, S., & Lin, W. H. (2003). Effectiveness of rhythm control in persistent or permanent atrial fibrillation with overdrive atrial pacing and antiarrhythmic drugs after linear right atrial catheter ablation. American Journal of Cardiology, 92, 1037–1044.PubMedCrossRefGoogle Scholar
  2. 2.
    Madan, N., & Saksena, S. (2004). Long-term rhythm control of drug refractory atrial fibrillation with “hybrid therapy” incorporating dual site right atrial pacing, antiarrhythmic drugs, and right atrial ablation. American Journal of Cardiology, 93, 569–575.PubMedCrossRefGoogle Scholar
  3. 3.
    Saksena, S., Prakash, A., Krol, R. B., & Shankar, A. (1999). Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. American Journal of Cardiology, 84, 880–889.PubMedCrossRefGoogle Scholar
  4. 4.
    Saksena, S., Skadsberg, N., Rao, B. H., & Filipecki, A. (2005). Biatrial and 3-Dimensional mapping of spontaneous atrial arrhythmias in patients with refractory atrial fibrillation. Journal of Cardiovascular Electrophysiology, 16(5), 494–504 (May).PubMedCrossRefGoogle Scholar
  5. 5.
    Fitts, S. M., Hill, M. R. S., Mehra, R., Friedman, P., Hammill, S., Kay, G. N., et al. (1998). Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. Journal of Interventional Cardiac Electrophysiology, 2, 139–144.PubMedCrossRefGoogle Scholar
  6. 6.
    Fuster, V., Ryden, L. E., Asinger, R. W., Cannom, D. S., Crijns, H. J., Frye, R. L., et al. (2001). ACC/ AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/ American Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Journal of the American College of Cardiology, 38, 1231–1266.PubMedCrossRefGoogle Scholar
  7. 7.
    Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., et al. (2002). A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. New England Journal of Medicine, 347(23), 1834–1840 (December 5).PubMedCrossRefGoogle Scholar
  8. 8.
    Carlsson, J., Miketic, S., Windeler, J., Cuneo, A., Haun, S., Micus, S., et al. (2003). Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: The Strategies of Treatment of Atrial Fibrillation (STAF) study. Journal of the American College of Cardiology, 41, 1690–1696.PubMedCrossRefGoogle Scholar
  9. 9.
    Oral, H., Gerstenfeld, E. P., Callans, D. J., Dixit, S., Zado, E., & Marchlinski, F. E. (2003). Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: Implications for ablation strategies. Journal of Cardiovascular Electrophysiology, 14(7), 685–690 (July).CrossRefGoogle Scholar
  10. 10.
    Liu, X., Dong, J., Mavrakis, H. E., Hu, F., Long, D., Fang, D., et al. (2006). Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: A randomized comparison between two different isolation approaches. Journal of Cardiovascular Electrophysiology, 17, 1263–1270.PubMedCrossRefGoogle Scholar
  11. 11.
    Wilkoff, B. L. (2003). The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: Rationale, design, results, clinical implications and lessons for future trials. Cardiac Electrophysiology Review, 7(4), 468–472 (Dec).PubMedCrossRefGoogle Scholar
  12. 12.
    Kay, G. N., Ellenbogen, K. A., Giudici, M., Redfield, M. M., Jenkins, L. S., Mianulli, M., et al. (1998). The Ablate and Pace Trial: A prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. Journal of Interventional Cardiac Electrophysiology, 2(2), 121–135 (June).PubMedCrossRefGoogle Scholar
  13. 13.
    Prakash, A., Delfaut, P., Krol, R. B., & Saksena, S. (1998). Regional right and left atrial activation patterns during single and dual site pacing in patients with atrial fibrillation. American Journal of Cardiology, 82, 1197–1204.PubMedCrossRefGoogle Scholar
  14. 14.
    Saksena, S., Prakash, A., Ziegler, P., Hummel, J. D., Friedman, P., Plumb, V. J., et al. (2002). DAPPAF Investigators. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. Journal of the American College of Cardiology, 40(6), 1140–1150 (Sep 18).PubMedCrossRefGoogle Scholar
  15. 15.
    Prakash, A., Saksena, S., Ziegler, P. D., Lokhandwala, T., Hettrick, D., Delfaut, P., et al. (2005). Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: Further observations from the Dual site Atrial pacing for Prevention of Atrial Fibrillation trial. Journal of Interventional Cardiac Electrophysiology, 12, 177–187 (April 3)Google Scholar
  16. 16.
    Saksena, S., & Madan, N. (2003). Hybrid therapy of atrial fibrillation: Algorithms and outcome. Journal of Interventional Cardiac Electrophysiology, 9, 235–247.PubMedCrossRefGoogle Scholar
  17. 17.
    Page, R. L., Tilsch, T. W., Connolly, S. J., Schnell, D. J., Marcello, S. R., Wilkinson, W. E., et al. (2003). Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators. Asymptomatic or “silent” atrial fibrillation: Frequency in untreated patients and patients receiving azimilide. Circulation, 107(8), 1141–1145 (March 4).PubMedCrossRefGoogle Scholar
  18. 18.
    Defaye, P., Dournaux, F., & Mouton, E. (1998). Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing and Clinical Electrophysiology, 21(1 Pt 2), 250–255 (January).PubMedCrossRefGoogle Scholar
  19. 19.
    Israel, C. W., Grönefeld, G., Ehrlich, J. R., Li, Y. G., & Hohnloser, S. H. (2004). Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care-. Journal of the American College of Cardiology, 43, 47–52.PubMedCrossRefGoogle Scholar
  20. 20.
    Bhandari, A. K., Anderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., et al. (1992). Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group. American Heart Journal, 124(2), 381–386 (August).PubMedCrossRefGoogle Scholar
  21. 21.
    Strickberger, S. A., John, Ip., Saksena, S., Curry, K., Bahnson, T., & Ziegler, P. D. (2005). Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm, 2, 125–131.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen, S. A., Hsieh, M. H., Tai, C. T., Tsai, C. F., Prakash, V. S., Yu, W. C., et al. (1999). Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation, 100, 1879–1886 (November).PubMedGoogle Scholar
  23. 23.
    Oral, H., Knight, B. P., Ozaydin, M., Tada, H., Chug, A., & Hassan, S. (2002). Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. Journal of the American College of Cardiology, 40, 100–104.PubMedCrossRefGoogle Scholar
  24. 24.
    Hsu, L. F., Jais, P., Sanders, P., Garrigue, S., Hocini, M., Sacher, F., et al. (2004). Catheter ablation for atrial fibrillation in congestive heart failure. New England Journal of Medicine, 351(23), 2373–2383 (December 2).PubMedCrossRefGoogle Scholar
  25. 25.
    O”Neill, M. D., Jais, P., Takahashi, Y., Jonnson, A., Sacher, F., Hocini, M., et al. (2006). The stepwise ablation approach for chronic atrial fibrillation—Evidence for a cumulative effect. Journal Interventional Cardiac Electrophysiology, 16, 153–167.CrossRefGoogle Scholar
  26. 26.
    Cheema, A., Vasamreddy, C. R., Dalal, D., Marine, J. E., Dong, J., Henrikson, C., et al. (2006). Long-term single procedure efficacy of catheter ablation of atrial fibrillation. Jounal of Interventional Cardiac Electrophysiology, 15, 145–155.CrossRefGoogle Scholar
  27. 27.
    Saad, E. B., Rossillo, A., Saad, C. P., Martin, D. O., Bhargava, M., Erciyes, D., et al. (2003). Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation. Functional characterization, evolution, and influence of the ablation strategy. Circulation, 108, 3102–3107.PubMedCrossRefGoogle Scholar
  28. 28.
    Saad, E. B., Marrouche, N. F., Saad, C. P., Ha, E., Bash, D., & White, R. D. (2003). Pulmonary vein stenosis after catheter ablation of atrial fibrillation: Emergence of a new clinical syndrome. Annals of Internal Medicine, 138(8), 634–638 (April 15).PubMedGoogle Scholar
  29. 29.
    Nilsson, B., Chen, X., Pehrson, S., Jensen, H. L., Sondergaard, L., & Helvind, M. (2004). Acute fatal pulmonary vein occlusion after catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 11(2), 127–130 (October).PubMedCrossRefGoogle Scholar
  30. 30.
    Pappone, C., Oral, H., Santinelli, V., Vicedomini, G., Lang, C. C., Manguso, F., et al. (2004). Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation, 109(22), 2724–2726 (June 8).PubMedCrossRefGoogle Scholar
  31. 31.
    Bunch, T. J., Asirvatham, S. J., Friedman, P. A., Monahan, K., Munger, T. M., Rea, R. E., et al. (2005). Outcomes after cardiac perforation during radiofrequency ablation of the atrium. Journal of Cardiovascular Electrophysiology, 16(11), 1172–1179 (November).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  1. 1.Electrophysiology Research FoundationWarrenUSA
  2. 2.PBI Regional Medical CenterPassaicUSA
  3. 3.RWJ Medical SchoolNew BrunswickUSA
  4. 4.Electrophysiology Research FoundationWarrenUSA

Personalised recommendations